Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985; 2:1–8.Search in Google Scholar
Garratty G. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1989;5:97–106.10.21307/immunohematology-2019-1075Search in Google Scholar
Garratty G. Review: immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs. Immunohematology 1994;10:41–50.10.21307/immunohematology-2019-817Search in Google Scholar
Garratty G. Review: drug-induced immune hemolytic anemia; the last decade. Immunohematology 2004;20:138–46.10.21307/immunohematology-2019-440Search in Google Scholar
Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology 2007;23:105–19.10.21307/immunohematology-2019-328Search in Google Scholar
Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology 2014;30:44–54.10.21307/immunohematology-2019-098Search in Google Scholar
Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology 2014;30:85–94.10.21307/immunohematology-2019-102Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.10.1016/B978-0-443-08559-8.50012-1Search in Google Scholar
Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009:73–9.10.1182/asheducation-2009.1.7320008184Search in Google Scholar
Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143–50.10.1016/j.blre.2010.06.00420650555Search in Google Scholar
Garratty G. Drug-induced immune hemolytic anemia. Clin Adv Hematol Oncol 2010;8:98–101.Search in Google Scholar
Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 2012;11:635–42.10.1517/14740338.2012.67883222502777Search in Google Scholar
Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm. Transfusion 2007;47: 697–702.10.1111/j.1537-2995.2007.01173.x17381629Search in Google Scholar
Madoz P, Muñiz-Diaz E, Martinez C, et al. Fatal immune hemolytic anemia induced by aceclofenac (abstract). Transfusion 1997;37:36S.Search in Google Scholar
Manor E, Marmor A, Kaufman S, Leiba H. Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test. JAMA 1976;236:2777–8.10.1001/jama.1976.03270250045026Search in Google Scholar
Garratty G, Stuart B, Postoway N, Bueno R. Antibodies to acetaminophen/phenacetin in normal donors, unselected hospital patients, and a patient with intravascular hemolysis, thrombocytopenia, and renal failure (abstract). Transfusion 1980;20:648.Search in Google Scholar
González CA, Guzmán L, Nocetti G. Drug-dependent antibodies with immune hemolytic anemia in AIDS patients. Immunohematology 2003;19:10–15.10.21307/immunohematology-2019-467Search in Google Scholar
Bernasconi C, Bedarida G, Pollini G, Sartori S. Study of the mechanism of hemolysis in a case of acquired hemolytic anemia caused by pyramidon (in Italian). Haematologica 1961;46:697–720.Search in Google Scholar
Gmür J, Wälti M, Neftel KA. Amoxicillin-induced immune hemolysis. Acta Haematol 1985;74:230–3.10.1159/0002062263939067Search in Google Scholar
Salama A, Burger M, Mueller-Eckhardt C. Acute immune hemolysis induced by a degradation product of amphotericin B. Blut 1989;58:59–61.10.1007/BF003206482920217Search in Google Scholar
Thomson S, Williamson D. A case of ampicillin-induced haemolytic anemia. Can J Med Technol 1974;36:228–9.Search in Google Scholar
Bengtsson U, Ahlstedt S, Aurell M, Kaijser B. Antazoline-induced immune hemolytic anemia, hemoglobinuria, and acute renal failure. Acta Med Scand 1975;198:223–7.10.1111/j.0954-6820.1975.tb19531.x1180129Search in Google Scholar
Hubert D, Habibi B, Krulik M, Debray J. Immunoallergic hemolytic anemia with thrombocytopenia and acute renal failure induced by aspirin (in French). Presse Med 1984;13:2567–9.Search in Google Scholar
Bird GWG, Wingham J, Babb RG, Bacon P, Wood D. Azapropazone-associated antibodies. Vox Sang 1984;46: 336–7.10.1111/j.1423-0410.1984.tb00095.x6730430Search in Google Scholar
Salama A, Mueller-Eckhardt C, Kissel K, Pralle H, Seeger W. Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol 1984;58:525–31.10.1111/j.1365-2141.1984.tb04000.x6208933Search in Google Scholar
Salama A, Northoff H, Burkhardt H, Mueller-Eckhardt C. Carbimazole-induced immune haemolytic anaemia: role of drug-red blood cell complexes for immunization. Br J Haematol 1988;68:479–82.10.1111/j.1365-2141.1988.tb04240.x3377989Search in Google Scholar
Maloisel F, Kurtz JE, Andres E, Gorodetsky C, Dufour P, Oberling F. Platin salts-induced hemolytic anemia: cisplatin-and the first case of carboplatin-induced hemolysis. Anticancer Drugs 1995;6:324–6.10.1097/00001813-199504000-00018Search in Google Scholar
Stefanini M, Johnson NL. Positive antihuman globulin test in patients receiving carbromal. Am J Med Sci 1970;259:49–55.10.1097/00000441-197001000-000074392024Search in Google Scholar
Salama A, Mueller-Eckhardt C. Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. Br J Haematol 1987;66:263–6.10.1111/j.1365-2141.1987.tb01309.x3606962Search in Google Scholar
Branch DR, Berkowitz LR, Becker RL, et al. Extravascular hemolysis following the administration of cefamandole. Am J Hematol 1985;18:213–19.10.1002/ajh.28301802133970014Search in Google Scholar
Moake JL, Butler CF, Hewell GM, Cheek J, Spruell MA. Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity. Transfusion 1978;18:369–73.10.1046/j.1537-2995.1978.18378205151.x96555Search in Google Scholar
Malaponte G, Arcidiacono C, Mazzarino C, et al. Cephalosporin-induced hemolytic anemia in a Sicilian child. Hematology 2000;5:327–34.10.1080/10245332.2000.1174652727424561Search in Google Scholar
Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. “Immune complex” mediated intravascular hemolysis due to IgM cephalosporin dependent antibody. Transfusion 1987;27:460–3.10.1046/j.1537-2995.1987.27688071694.x3500531Search in Google Scholar
Eckrich RJ, Fox S, Mallory D. Cefotetan-induced immune hemolytic anemia due to the drug-adsorption mechanism. Immunohematology 1994;10:51–4.10.21307/immunohematology-2019-818Search in Google Scholar
Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32: 269–71.10.1046/j.1537-2995.1992.32392213813.x1557811Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239–46.10.1046/j.1537-2995.1999.39111239.x10604252Search in Google Scholar
Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002;21:101–7.10.1007/BF0325618412140903Search in Google Scholar
Davenport RD, Judd WJ, Dake LR. Persistence of cefotetan on red blood cells. Transfusion 2004;44:849–52.10.1111/j.1537-2995.2004.03360.xSearch in Google Scholar
Toy E, Nesbitt R, Savastano G, Fox S, Araneta M, Hsueh Y. Warm autoantibody following plasma apheresis complicated by acute intravascular hemolysis associated with cefoxitin-dependent antibody resulting in fatality (abstract). Transfusion 1989;29:51S.Search in Google Scholar
Novaretti MCZ, Sopeleti CR, Dorlhiac-Llacer PE, Chamone DA. Use of gel microcolumn assay for the detection of drug-induced positive direct antiglobulin tests. J Clin Lab Anal 2005;19:219–27.10.1002/jcla.20081Search in Google Scholar
Chambers LA, Donovan LM, Kruskall MS. Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991;95:393–6.10.1093/ajcp/95.3.393Search in Google Scholar
Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion 1999;39:838–44.10.1046/j.1537-2995.1999.39080838.xSearch in Google Scholar
Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176–9.10.1046/j.1537-2995.1991.31291142951.xSearch in Google Scholar
Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26:1390–4.10.1007/s001340000598Search in Google Scholar
Malloy CA, Kiss JE, Challapalli M. Cefuroxime-induced immune hemolysis. J Pediatr 2003;143:130–2.10.1016/S0022-3476(03)00210-5Search in Google Scholar
Manoharan A, Kot T. Cephalexin-induced haemolytic anaemia (letter). Med J Aust 1987;147:202.10.5694/j.1326-5377.1987.tb133379.x3657639Search in Google Scholar
Gralnick HR, Wright LD Jr, McGinniss MH. Coombs’ positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:725–6.10.1001/jama.1967.03120100087016Search in Google Scholar
Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs tests due to cephalothin. N Engl J Med 1967;277: 123–5.10.1056/NEJM1967072027703036054993Search in Google Scholar
Gralnick HR, McGinniss M, Elton W, McCurdy P. Hemolytic anemia associated with cephalothin. JAMA 1971;217:1193–7.10.1001/jama.1971.03190090015004Search in Google Scholar
Giro C, Verlicchi G, Baccarani M. Selective erythroblastic aplasia and hemolytic immunopathic type complement anemia in a patient treated with chloramphenicol (in Italian). G Clin Med 1970;51:112–18.Search in Google Scholar
Muirhead EE, Groves M, Guy R, Halden ER, Bass RK. Acquired hemolytic anemia, exposures to insecticides and positive Coombs’ test dependent on insecticide preparations. Vox Sang 1959;4:277–92.10.1111/j.1423-0410.1959.tb03629.x14425063Search in Google Scholar
Lindberg LG, Norden A. Severe hemolytic reaction to chlorpromazine. Acta Med Scand 1961;170:195–9.Search in Google Scholar
Logue GL, Boyd AE 3rd, Rosse WF. Chlorpropamide-induced immune hemolytic anemia. N Engl J Med 1970;283:900–4.10.1056/NEJM1970102228317045458054Search in Google Scholar
Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto anti-Jka. Transfusion 1984;24:206–9.10.1046/j.1537-2995.1984.24384225022.x6427987Search in Google Scholar
Arndt PA, Garratty G, Brasfield FM, Vemuri SL, Asuncion DJ. Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody. Transfusion 2010;50:302–7.10.1111/j.1537-2995.2009.02447.x19874564Search in Google Scholar
MacKay AD, Mehta A. Autoimmune haemolytic anaemia associated with ciprofloxacin. Clin Lab Haematol 1995;17: 97–8.Search in Google Scholar
Getaz EP, Beckley S, Fitzpatrick J, Dozier A. Cisplatin-induced hemolysis. N Engl J Med 1980;302:334–5.10.1056/NEJM1980020730206077188625Search in Google Scholar
Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988;28:493–5.10.1046/j.1537-2995.1988.28588337345.x3420679Search in Google Scholar
Schroeder ML, Taylor M, Anderson C, Albritton WL. Immune hemolysis in an infant with a staphylococcal infection (abstract). International Society of Blood Transfusion, Montreal, Canada 1980.Search in Google Scholar
Barbolla L, Fernandez MN, Bajo R, Arrieta R, Gilsanz F. Positive Coombs’ test due to synthetic estrogen therapy (bis(p-acetyloxiphenyl-cyclohexilydene)-methane) (in Spanish). Sangre 1974;19:99–104.Search in Google Scholar
De Vecchi A, Zanella A, Egidi F, Ponticelli C. Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine. Acta Haematol 1985;73:216–18.10.1159/0002063323933243Search in Google Scholar
Duran-Suarez JR, Martin-Vega C, Argelagues E, et al. The I antigen as an immune complex receptor in a case of haemolytic anaemia induced by an antihistaminic agent. Br J Haematol 1981;49:153–4.10.1111/j.1365-2141.1981.tb07208.x6115667Search in Google Scholar
Ciucci AG. A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). Rheumatol Rehabil 1979;(Suppl2):116–21.Search in Google Scholar
Salama A, Göttsche B, Mueller-Eckhardt C. Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77:546–9.10.1111/j.1365-2141.1991.tb08624.x2025580Search in Google Scholar
Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C. Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 1996;95:640–4.10.1046/j.1365-2141.1996.d01-1947.xSearch in Google Scholar
Ahrens N, Genth R, Kiesewetter H, Salama A. Misdiagnosis in patients with diclofenac-induced hemolysis: new cases and a concise review. Am J Hematol 2006;81:128–31.10.1002/ajh.20494Search in Google Scholar
Rosenfeld CS, Winters SJ, Tedrow HE. Diethylstilbestrol-associated hemolytic anemia with a positive direct antiglobulin test result. Am J Med 1989;86:617–8.10.1016/0002-9343(89)90397-5Search in Google Scholar
Lay WH. Drug-induced haemolytic reactions due to antibodies against the erythrocyte/dipyrone complex. Vox Sang 1966; 11:601–10.Search in Google Scholar
Wong KY, Boose GM, Issitt CH. Erythromycin-induced hemolytic anemia. J Pediatr 1981;98:647–9.10.1016/S0022-3476(81)80787-1Search in Google Scholar
Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000;40:663–8.10.1046/j.1537-2995.2000.40060663.x10864985Search in Google Scholar
Mayer B, Genth R, Dehner R, Salama A. The first example of a patient with etoricoxib-induced immune hemolytic anemia. Transfusion 2013;53:1033–6.10.1111/j.1537-2995.2012.03843.x22882551Search in Google Scholar
Shirey RS, Morton SJ, Lawton KB, Lowell C, Kickler TS, Ness PM. Fenoprofen-induced immune hemolysis: difficulties in diagnosis and complications in compatibility testing. Am J Clin Pathol 1988;89:410–14.10.1093/ajcp/89.3.4103348176Search in Google Scholar
Munizza M, Kavitsky D, Schainker BA, Poyser A, Peek C, Nance S. Hemolytic anemia associated with injection of fluorescein. Transfusion 1993;33:689–92.10.1046/j.1537-2995.1993.33893342754.x8342239Search in Google Scholar
Sandvei P, Nordhagen R, Michaelsen TE, Wolthuis K. Fluorouracil (5-FU) induced acute immune haemolytic anaemia. Br J Haematol 1987;65:357–9.10.1111/j.1365-2141.1987.tb06868.x3567089Search in Google Scholar
Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139–43.10.1111/j.1365-2141.1985.tb04069.x2864949Search in Google Scholar
Vassal T, Lentzy M, Maury E, Guidet B, Offenstadt G. Severe immunoallergic hemolytic anemia caused by a glafenine metabolite (in French). Presse Med 1991;20:1434–6.Search in Google Scholar
Orenstein AA, Yakulis V, Eipe J, Costea N. Immune hemolysis due to hydralazine (letter). Ann Intern Med 1977;86:450–1.10.7326/0003-4819-86-4-450848811Search in Google Scholar
Vila JM, Blum L, Dosik H. Thiazide-induced immune hemolytic anemia. JAMA 1976;236:1723–4.10.1001/jama.1976.03270160045029Search in Google Scholar
Criel AM, Hidajat M, Clarysse A, Verwilghen RL. Drug dependent red cell antibodies and intravascular haemolysis occurring in patients treated with 9-hydroxy-methyl-ellipticinium. Br J Haematol 1980;46:549–56.10.1111/j.1365-2141.1980.tb06011.x7437333Search in Google Scholar
Martinengo M, Ardenghi DF, Tripodi G, Reali G. The first case of drug-induced immune hemolytic anemia due to hydrocortisone. Transfusion 2008;48:1925–9.10.1111/j.1537-2995.2008.01797.x18565121Search in Google Scholar
Korsager S. Haemolysis complicating ibuprofen treatment. Br Med J 1978;1:79.10.1136/bmj.1.6105.791602601620207Search in Google Scholar
Novaretti MCZ, Fonseca GHH, Conchon M, Dorlhiac-Llacer PE, Chamone DAF. First case of immune-mediated haemolytic anaemia associated to imatinib mesylate. Eur J Haematol 2003;71:455–8.10.1046/j.0902-4441.2003.00128.x14703696Search in Google Scholar
Faulk WP, Tomsovic EJ, Fudenberg HH. Insulin resistance in juvenile diabetes mellitus. Am J Med 1970;49:133–9.10.1016/S0002-9343(70)80123-1Search in Google Scholar
Mayer B, Leo A, Herziger A, Houben P, Schemmer P, Salama A. Intravascular immune hemolysis caused by the contrast medium iomeprol. Transfusion 2013;53:2141–4.10.1111/trf.1208923347254Search in Google Scholar
Robinson MG, Foadi A. Hemolytic anemia with positive Coombs’ test. Association with isoniazid therapy. JAMA 1969; 208:656–8.10.1001/jama.1969.03160040064007Search in Google Scholar
Oh YR, Carr-Lopez SM, Probasco JM, Crawley PG. Levofloxacin-induced autoimmune hemolytic anemia. Ann Pharmacother 2003;37:1010–13.10.1345/aph.1C52512841809Search in Google Scholar
Arndt PA, Garratty G, Maranto LS, Wohl H. Immune hemolytic anemia associated with mefloquine (letter). Transfusion 1997; 37:1220–1.10.1046/j.1537-2995.1997.37111298088058.x9426652Search in Google Scholar
Eyster ME. Melphalan (Alkeran) erythrocyte agglutinin and hemolytic anemia. Ann Intern Med 1967;66:573–7.10.7326/0003-4819-66-3-5736019232Search in Google Scholar
Pujol M, Fernández F, Sancho JM, Ribera JM, Millá F, Feliu E. Immune hemolytic anemia induced by 6-mercaptopurine. Transfusion 2000;40:75–6.10.1046/j.1537-2995.2000.40010075.x10644815Search in Google Scholar
Sivamurthy S, Frankfurt E, Levine ME. Positive antiglobulin tests in patients maintained on methadone. Transfusion 1973; 13:418–21.10.1111/j.1537-2995.1973.tb04470.x4749645Search in Google Scholar
Nordhagen R, Vik H, Wolthuis K, Bohn HP, Urdahl P, Michaelsen TE. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium. Transfusion 1991;31:843–6.10.1046/j.1537-2995.1991.31992094673.x1755090Search in Google Scholar
Kudoh T, Nagata N, Suzuki N, Nakata S, Chiba S, Takahashi T. Minocycline-induced hemolytic anemia. Acta Paediatr Jpn 1994;36:701–4.10.1111/j.1442-200X.1994.tb03274.x7871987Search in Google Scholar
Johnson ST, Bandouveres S, Aster RH, Bougie D. Nabumetone metabolite-dependent antibody reacting with untreated red cells in the presence of urinary metabolite (abstract). Transfusion 2003;43:101A.Search in Google Scholar
Kroovand S, Kirtland HH, Issitt CH. A positive direct antiglobulin test due to sodium nafcillin (abstract). Transfusion 1977;17:682.Search in Google Scholar
Lo TZH, Martin MA. Autoimmune haemolytic anaemia associated with naproxen suppositories. BMJ 1986;292:1430.Search in Google Scholar
Duran-Suarez JR, Martin-Vega C, Argelagues E, Massuet L, Ribera A, Triginer J. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41:313–15.10.1111/j.1423-0410.1981.tb01055.x7324446Search in Google Scholar
Bournerias F, Nabibi B. Nomifensine-induced immune haemolytic anaemia and impaired renal function (letter). Lancet 1979;2:95–6.10.1016/S0140-6736(79)90144-2Search in Google Scholar
Abad A, López P, Bauza J. Norfloxacin-induced positive direct antiglobulin test (letter). Vox Sang 1999;77:238.10.1046/j.1423-0410.1999.7740238.xSearch in Google Scholar
Desrame J, Broustet H, Darodes de Tailly P, Girard D, Saissy JM. Oxaliplatin-induced haemolytic anaemia. Lancet 1999;354:1179–80.10.1016/S0140-6736(99)03827-1Search in Google Scholar
Arndt PA, Garratty G, Isaak E, Bolger M, Lu Q. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Transfusion 2009;49:711–18.10.1111/j.1537-2995.2008.02028.xSearch in Google Scholar
MacGibbon BH, Loughridge LW, Hourihane DO, Boyd DW. Autoimmune haemolytic anaemia with acute renal failure due to phenacetin and p-aminosalicylic acid. Lancet 1960;1:7–10.10.1016/S0140-6736(60)92714-8Search in Google Scholar
Park GM, Han KS, Chang YH, Kim CH, Lee JC. Immune hemolytic anemia after treatment with pemetrexed for lung cancer (letter). J Thorac Oncol 2008;3:196–7.10.1097/JTO.0b013e31815e8bca18303446Search in Google Scholar
Strumia PV, Raymond FD. Acquired hemolytic anemia and antipenicillin antibody. Case report and review of literature. Arch Intern Med 1962;109:603–8.10.1001/archinte.1962.0362017010101713917894Search in Google Scholar
Petz LD, Fudenberg HH. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med 1966; 274:171–8.10.1056/NEJM1966012727404014159252Search in Google Scholar
Muirhead EE, Halden ER, Groves M. Drug-dependent Coombs (antiglobulin) test and anemia; observations on quinine and acetophenetidin (phenacetin). Arch Intern Med 1958;101: 87–96.10.1001/archinte.1958.0026013010101013486970Search in Google Scholar
Johnson ST, Weitekamp LA, Sauer DE, Fueger JT, Aster RH. Piperacillin-dependent antibody with relative e specificity reacting with drug treated red cells and untreated red cells in the presence of drug (abstract). Transfusion 1994;34:70S.Search in Google Scholar
Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Immune hemolytic anemia associated with probenecid. Am J Clin Pathol 1985;84:391–4.10.1093/ajcp/84.3.3914036870Search in Google Scholar
Rubio-Martínez A, García-Erce JA, Salvador C, Gómez-Arteta E, Gimeno JJ. Autoimmune haemolytic anaemia induced by propyphenazone (letter). Vox Sang 1998;75:257.10.1046/j.1423-0410.1998.75302571.xSearch in Google Scholar
Chen F, Liu S, Wu J. Puerarin-induced immune hemolytic anemia. Int J Hematol 2013;98:112–13.10.1007/s12185-013-1357-123661032Search in Google Scholar
Freedman AL, Barr PS, Brody EA. Hemolytic anemia due to quinidine: observations on its mechanism. Am J Med 1956; 20:806–16.10.1016/0002-9343(56)90164-4Search in Google Scholar
Pixley JS, MacKintosh FR, Sahr EA, Zanjani ED. Mechanism of ranitidine associated anemia. Am J Med Sci 1989;297: 369–71.10.1097/00000441-198906000-00007Search in Google Scholar
Blajchman MA, Lowry RC, Pettit JE, Stradling P. Rifampicin-induced immune thrombocytopenia. Br Med J 1970;3:24–6.10.1136/bmj.3.5713.24Search in Google Scholar
Worlledge S. Hong Kong Treatment Services–Royal Postgraduate Medical School–British Medical Research Council Co-operative Study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies. Scand J Respir Dis 1973;84:60–3.Search in Google Scholar
Worlledge S. Hong Kong Treatment Services–Royal Post-graduate Medical School–British Medical Research Council Co-operative Study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data. Scand J Respir Dis 1973;84:125–8.Search in Google Scholar
Harris JW. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med 1956;47:760–75.Search in Google Scholar
Mathiesen O, Grunnet N. Haemolysis after intravenous streptokinase (letter). Lancet 1989;1:1016–17.10.1016/S0140-6736(89)92656-1Search in Google Scholar
Letona JM, Barbolla L, Frieyro E, Bouza E, Gilsanz F, Fernández MN. Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561–71.10.1111/j.1365-2141.1977.tb00621.x405985Search in Google Scholar
Florendo NT, MacFarland D, Painter M, Muirhead EE. Streptomycin-specific antibody coincident with a developing warm autoantibody. Transfusion 1980;20:662–8.10.1046/j.1537-2995.1980.20681057155.x7434449Search in Google Scholar
Fernández MN, Barbolla L. Streptomycin-specific antibodies (letter). Transfusion 1982;22:344–5.10.1046/j.1537-2995.1982.22482251230.x7101433Search in Google Scholar
Teplitsky V, Virag I, Halabe A. Immune complex haemolytic anaemia associated with sulfasalazine. BMJ 2000;320:1113.Search in Google Scholar
Johnson FP Jr, Hamilton HE, Liesch MR. Immune hemolytic anemia associated with sulindac. Arch Intern Med 1985;145:1515–16.10.1001/archinte.1985.00360080197030Search in Google Scholar
van Dijk BA, Rico PB, Hoitsma A, Kunst VA. Immune hemolytic anemia associated with tolmetin and suprofen. Transfusion 1989;29:638–41.10.1046/j.1537-2995.1989.29789369685.x2773031Search in Google Scholar
Law IP, Wickman CJ, Harrison BR. Coombs’-positive hemolytic anemia and ibuprofen. South Med J 1979;72: 707–10.10.1097/00007611-197906000-00022451658Search in Google Scholar
Coluccio E, Villa MA, Villa E, et al. Immune hemolytic anemia associated with teicoplanin. Transfusion 2004;44:73–6.10.1111/j.0041-1132.2003.00599.xSearch in Google Scholar
Maguire RB, Stroncek DF, Gale E, Yearlsey M. Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am J Hematol 1994;46:363–6.10.1002/ajh.2830460420Search in Google Scholar
Habibi B, Lopez M, Serdaru M, et al. Immune hemolytic anemia and renal failure due to teniposide. N Engl J Med 1982;306:1091–3.10.1056/NEJM198205063061806Search in Google Scholar
Wenz B, Klein RL, Lalezari P. Tetracycline-induced immune hemolytic anemia. Transfusion 1974;14:265–9.10.1111/j.1537-2995.1974.tb04529.xSearch in Google Scholar
Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. Specific involvement of red-cell antigen I. N Engl J Med 1985;312: 353–5.10.1056/NEJM198502073120606Search in Google Scholar
Arndt PA, Wolf CF, Kripas CJ, Garratty G. First example of an antibody to ticarcillin: a possible cause of hemolytic anemia (abstract). Transfusion 1999;39:47S.Search in Google Scholar
Bird GW, Eeles GH, Litchfield JA, Rahman M, Wingham J. Haemolytic anaemia associated with antibodies to tolbutamide and phenacetin. Br Med J 1972;1:728–9.10.1136/bmj.1.5802.728Search in Google Scholar
Leitman SF, Lee BJ, McGinniss MH, Shulman NR, Frank MM. Massive immune hemolysis, disseminated intravascular coagulation (DIC), and acute renal failure in association with tolmetin ingestion (abstract). Transfusion 1984;24:426.Search in Google Scholar
Takahashi H, Tsukada T. Triamterene-induced immune haemolytic anaemia with acute intravascular haemolysis and acute renal failure. Scand J Haematol 1979;23:169–76.10.1111/j.1600-0609.1979.tb02688.xSearch in Google Scholar
Ahmad D, Morgan WK, Patterson R, Williams T, Zeiss CR. Pulmonary haemorrhage and haemolytic anaemia due to trimellitic anhydride. Lancet 1979;2:328–30.10.1016/S0140-6736(79)90344-1Search in Google Scholar
Ermis B, Caner I, Karacan M, Olgun H. Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use (letter). Thromb Haemost 2003;90:158–9.10.1055/s-0037-1613614Search in Google Scholar
Betensky M, Fisher MJ, Nance SJ, Weiss M, Witmer C, Sesok-Pizzini D. Carboplatin and vincristine induced hemolytic anemia in a pediatric patient with an optic pathway glioma (abstract). Transfusion 2013;(53Suppl):32A.Search in Google Scholar
Schulenburg BJ, Beck ML, Pierce SR, Plapp FV, Cooper DG. Immune hemolysis associated with ZomaxTM (abstract). Transfusion 1983;23:409.Search in Google Scholar
Elimelakh M, Dayton V, Park KS, et al. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenalate, and daclizumab in pancreas transplant recipients. Haematologica 2007;92: 1029–36.10.3324/haematol.1073317640860Search in Google Scholar
Goldschmidt N, Gural A, Ben-Yehuda D, Gatt ME. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia. Cancer Chemother Pharmacol 2013;72:709–13.10.1007/s00280-013-2243-5Search in Google Scholar
Luderer JR, Schoolwerth AC, Sinicrope RA, Ballard JO, Lookingbill DP, Hayes AH Jr. Acute renal failure, hemolytic anemia and skin rash associated with captopril therapy. Am J Med 1981;71:493–6.10.1016/0002-9343(81)90187-XSearch in Google Scholar
Tregellas WM, South SF. Autoimmune syndrome induced by chaparral ingestion (abstract). Transfusion 1980;20:647–8.Search in Google Scholar
Rotoli B, Formisano S, Alfinito F. Autoimmune haemolytic anaemia associated with cimetidine (letter). Lancet 1979;2:583.10.1016/S0140-6736(79)91637-4Search in Google Scholar
Fleischman RA, Croy D. Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia (letter). Am J Hematol 1995; 48:293.10.1002/ajh.2830480423Search in Google Scholar
Nussey AM. Fenfluramine and haemolytic anaemia (letter). Br Med J 1973;1:177–8.10.1136/bmj.1.5846.177-eSearch in Google Scholar
Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia (letter). Ann Oncol 1992;3:171–2.10.1016/S0923-7534(19)65168-9Search in Google Scholar
Di Raimondo F, Giustolisi R, Cacciola E, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 1993;11:63–8.10.3109/10428199309054731Search in Google Scholar
Akard LP, Hoffman R, Elias L, Saiers JH. Alpha-interferon and immune hemolytic anemia (letter). Ann Intern Med 1986; 105:306–7.10.7326/0003-4819-105-2-306_1Search in Google Scholar
Perez R, Padavic K, Krigel R, Weiner L. Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon. Cancer 1991;67:2512–17.10.1002/1097-0142(19910515)67:10<2512::AID-CNCR2820671021>3.0.CO;2-5Search in Google Scholar
Umstead GS, Babiak LM, Tejwani S. Immune hemolytic anemia associated with ketoconazole therapy. Clin Pharm 1987;6:499–500.Search in Google Scholar
Darabi K, Kantamnei S, Wiernik PH. Lenalidomide-induced warm autoimmune hemolytic anemia. J Clin Oncol 2006; 24:e59.10.1200/JCO.2006.08.4053Search in Google Scholar
Cotzias GC, Papavasiliou PS. Autoimmunity in patients treated with levodopa (letter). JAMA 1969;207:1353–4.10.1001/jama.1969.03150200119022Search in Google Scholar
Scott GL, Myles AB, Bacon PA. Autoimmune haemolytic anaemia and mefenamic acid therapy. Br Med J 1968;3:534–5.10.1136/bmj.3.5617.53419864585676955Search in Google Scholar
Snapper I, Marks D, Schwartz L, Hollander L. Hemolytic anemia secondary to mesantoin. Ann Intern Med 1953;39: 619–23.10.7326/0003-4819-39-3-61913080906Search in Google Scholar
Carstairs K, Worlledge S, Dollery CT, Breckenridge A. Methyldopa and haemolytic anaemia (letter). Lancet 1966; 1:201.Search in Google Scholar
Gilbertson C, Jones DR. Haemolytic anaemia with nalidixic acid (letter). Br Med J 1972;4:493.10.1136/bmj.4.5838.493-a17867284653901Search in Google Scholar
Jones GW, George TL, Bradley RD. Procainamide-induced hemolytic anemia. Transfusion 1978;18:224–7.10.1046/j.1537-2995.1978.18278160589.x417435Search in Google Scholar
Kleinman S, Nelson R, Smith L, Goldfinger D. Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide. N Engl J Med 1984;311:809–12.10.1056/NEJM1984092731113016332273Search in Google Scholar
Jourdan E, Topart D, Richard B, Jourdan J, Sotto A. Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder. Leuk Lymphoma 2003;44:889–90.10.1080/104281902100005511012802933Search in Google Scholar
DiGiuseppe JA, Bastacky SI, Shirey RS, Silberman MA, Hutchins GM, Ness PM. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. Arch Pathol Lab Med 1996;120:282–5.Search in Google Scholar
Shen Y. Autoimmune hemolytic anemia associated with a formulation of traditional Chinese medicines. Am J HealthSyst Pharm 2009;66:1701–3.10.2146/ajhp08052519767374Search in Google Scholar
Williams ME, Thomas D, Harman CP, Mintz PD, Donowitz GR. Positive direct antiglobulin tests due to clavulanic acid. Antimicrob Agents Chemother 1985;27:125–7.10.1128/AAC.27.1.1251762173872623Search in Google Scholar
Garratty G, Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998;100:777–83.10.1046/j.1365-2141.1998.00615.x9531349Search in Google Scholar
Smith RL, Gralnick MA, Cysyk RL, Gralnick HR. Red cell alterations by a new chemotherapeutic agent (abstract). Transfusion 1974;14:513.Search in Google Scholar
Jamin D, Demers J, Shulman I, Lam HT, Momparler R. An explanation for nonimmunologic adsorption of proteins onto red blood cells: Schiff’s base reactions. Blood 1986;67:993–6.10.1182/blood.V67.4.993.993Search in Google Scholar
Lutz P, Dzik W. Very high incidence of a positive direct antiglobulin test (+DAT) in patients receiving Unasyn (abstract). Transfusion 1992;32:23S.Search in Google Scholar
Jamin D, Shulman I, Lam HT, et al. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med 1988;112:898–900.Search in Google Scholar
Broadberry RE, Farren TW, Bevin SV, et al. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG on patient’s red cells. Transfus Med 2004;14:53–7.10.1111/j.0958-7578.2004.00481.x15043594Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells (letter). Vox Sang 2003;85:53.10.1046/j.1423-0410.2003.00323.x12823734Search in Google Scholar
Salama A, Mayer B. Diagnostic pitfalls of drug-induced hemolytic anemia. Immunohematology 2014;30:80–84.10.21307/immunohematology-2019-101Search in Google Scholar
Habibi B, Bretagne Y. Blood group antigens may be the receptors for specific drug-antibody complexes reacting with red blood cells (in French). CR Seances Acad Sc III 1983;296:693–6.Search in Google Scholar
Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68:1285–8.10.1182/blood.V68.6.1285.1285Search in Google Scholar
Arndt PA, Revilla J, Leger RM, Garratty G. Studies on specificity of selected drug-dependent antibodies (abstract). Transfusion 2013;(53Suppl):17A.Search in Google Scholar
Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion 2008;48:2429–34.10.1111/j.1537-2995.2008.01852.x18657075Search in Google Scholar
Leger RM, Garratty G. Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors. Transfusion 2011;51:1740–4.10.1111/j.1537-2995.2010.03040.x21303372Search in Google Scholar
Arndt PA, Leger RM, Garratty G. IgM agglutinins to meropenem, a beta-lactam antibiotic, are found in plasma of healthy blood donors and random patients (abstract). Transfusion 2012;(52Suppl):26A.Search in Google Scholar
Hamblin TJ, Orchard JA, Myint H, Oscier DG. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia. J Clin Oncol 1998;16:3209–10.10.1200/JCO.1998.16.9.32099738600Search in Google Scholar
Myint H, Copplestone JA, Orchard J, et al. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995;91:341–4.10.1111/j.1365-2141.1995.tb05300.x8547072Search in Google Scholar
Gonzalez H, Leblond V, Azar N, et al. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Hematol Cell Ther 1998;40:113–18.Search in Google Scholar
Dearden C, Wade R, Else M, et al.; UK National Cancer Research Institute (NCRI); Haematological Oncology Clinical Studies Group; NCRI CLL Working Group. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood 2008;111:1820–6.10.1182/blood-2007-07-10130318055869Search in Google Scholar
Hamblin TJ. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 2006;33:230–9.10.1053/j.seminoncol.2006.01.01116616070Search in Google Scholar
Borthakur G, O’Brien S, Wierda WG, et al. Immune anaemias in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide and rituximab—incidence and predictors. Br J Haematol 2007;136:800–5.10.1111/j.1365-2141.2007.06513.x17341265Search in Google Scholar
Glance LE, Cumpston A, Kanate A, Remick SC. Bendamustine-associated hemolytic anemia. Ann Pharmacol 2009;43: 1903–6.10.1345/aph.1M32919809007Search in Google Scholar
